Plain-English translation of NCT07268859 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a simple, non-medical intervention—hand fanning—can help prevent or reduce shortness of breath that some people experience when taking ticagrelor after a heart attack. Ticagrelor is a blood-thinning medication that's important for heart attack recovery, but it can cause breathing difficulties in some patients. Researchers want to see if gently fanning a patient's face during the first two hours after taking this medication might ease those breathing problems.
Shortness of breath is a common and bothersome side effect of this medication, and it sometimes causes patients to stop taking a treatment they need. This trial is looking for a simple, safe, and low-cost way to help patients tolerate the medication better without adding drugs or invasive procedures.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you'll be randomly assigned to either receive standard care alone or standard care plus hand fan therapy. Both groups will stay in the coronary care unit and receive positioning help and breathing exercises. If you're in the fan therapy group, a researcher will gently fan your face for 5 minutes at three time points (30, 60, and 120 minutes) after you take the medication. Throughout the first 2 hours, medical staff will monitor and record any breathing difficulties you experience.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Turkey (Türkiye)